The antidiabetic gutsy role of metformin uncovered?

@article{Burcelin2013TheAG,
  title={The antidiabetic gutsy role of metformin uncovered?},
  author={R{\'e}my Burcelin},
  journal={Gut},
  year={2013},
  volume={63},
  pages={706 - 707}
}
Why are grams of metformin recommended to lower hyperglycaemia in type 2 diabetic patients whereas the dose ranges from micrograms to milligrams for all other antidiabetic agents? Why is that 50% of the patients should discontinue or reduce the daily therapeutic doses to avoid diarrhoea? Why has the previously established mode of action of metformin been continuously disputed and re-evaluated by the scientific community? To these questions, Shin et al 1 shifted again the paradigm related to… Expand
Metformin Use in Adolescents: Old and New Therapeutic Perspectives
TLDR
The old and new therapeutic perspectives of this drug are presented and many investigators and physician to use it as the primary drug of choice in these conditions for both prevention and treatment are presented. Expand
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.
TLDR
Metformin has a direct and AMPK-dependent effect on GLP-1-secreting L cells and increases postprandial GLP1 secretion, which seems to contribute to metformin's glucose-lowering effect and mode of action. Expand
Prevention and Treatment of Obesity and Diabetes and their Related Complications
TLDR
The currently available diabetes and obesity therapies are summarized and the effective and safe ability of Cyclo-Z is illustrated to reduce and treat patients suffering from diabetes and Obesity is summarized. Expand
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.
  • L. Nesti, A. Natali
  • Medicine
  • Nutrition, metabolism, and cardiovascular diseases : NMCD
  • 2017
TLDR
The overall evidence emerging from both clinical trials and real world registry is in favor of a protective effect of metformin with respect to both coronary events and progression to heart failure. Expand
Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice
TLDR
This study proposes that combining probiotics and/or prebiotics with antidiabetic drugs improves glycemic control and insulin sensitivity in mice. Expand
Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case–control study
TLDR
In diabetic patients, in addition to the well-recognized risk factors, heart failure is an additional risk factor for CDI, while metformin treatment seems to have a protective effect against the development of CDI. Expand
Metformin like Stress Response Modulating Effects of Turmeric Curcuminoids in Mice
TLDR
Comparisons of protective efficacies of a single and repeated daily oral doses of a Curcuma longa extract enriched in curcuminoids against intermittent foot shock stress triggered body weight changes and thermoregulatory responses in male and female mice reveal that C. longa could be functionally a metformin-like desensitizer of biological mechanisms and processes involved in stress triggered thermoreGulatory and other physiological responses. Expand
Impact of metformin on the therapeutic effect of radiotherapy
TLDR
The use of metformin as an adjuvant with radiotherapy should be treated with caution, as further studies investigating its optimal dose as well as molecular mechanisms are still needed. Expand
Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect
TLDR
The findings suggested that metformin might produce a synergistic colon cancer‐preventative effect in diabetic patients through the regulation of the enzymes expression involved in glucose metabolism. Expand
The Use of Anti-Diabetic Drugs in Alzheimer’s Disease, New Therapeutic Options and Future Perspective
TLDR
It is concluded that antidiabetics have good potential to improve dementia, especially in earlier AD stages, however, many of the underlying intricate molecular pathways are still unclear and thus thorough future research is required. Expand
...
1
2
...

References

SHOWING 1-10 OF 11 REFERENCES
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
TLDR
Modulation of the gut microbiota (by an increase in the Akkermansia spp. population) may contribute to the antidiabetic effects of metformin, thereby providing a new mechanism for the therapeutic effect of met formin in patients with T2D. Expand
Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP
TLDR
A novel mechanism by which metformin antagonizes the action of glucagon, thus reducing fasting glucose levels and suggesting an approach for the development of antidiabetic drugs is provided. Expand
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects.
TLDR
Metformin significantly increases GLP-1 levels after an oral glucose load in obese nondiabetic subjects; this effect could be due to an inhibition of GLP(7-36)amide degradation. Expand
Role of AMP-activated protein kinase in mechanism of metformin action.
TLDR
It is reported that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidation is induced, and expression of lipogenic enzymes is suppressed. Expand
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
TLDR
It is concluded that the LPS/CD14 system sets the tone of insulin sensitivity and the onset of diabetes and obesity and lowering plasma LPS concentration could be a potent strategy for the control of metabolic diseases. Expand
Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
TLDR
The mitochondrial effects of metformin are probably crucial in explaining the various properties of this drug and may explain its unique efficacy in the treatment of hyperglycaemia- or insulin-resistance related complications. Expand
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
TLDR
Substantial insight is provided into the intricate mechanisms of bacterial regulation of the cross-talk between the host and gut microbiota and provides a rationale for the development of a treatment that uses this human mucus colonizer for the prevention or treatment of obesity and its associated metabolic disorders. Expand
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
TLDR
It is demonstrated that the early onset of HFD‐induced hyperglycemia is characterized by an increased bacterial translocation from intestine towards tissues, fuelling a continuous metabolic bacteremia, which could represent new therapeutic targets. Expand
A metagenome-wide association study of gut microbiota in type 2 diabetes
TLDR
MGWAS analysis showed that patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens, as well as an enrichment of other microbial functions conferring sulphate reduction and oxidative stress resistance. Expand
NOD1 Activators Link Innate Immunity to Insulin Resistance
TLDR
Acute activation of NOD proteins by mimetics of bacterial PGNs causes whole-body insulin resistance, bolstering the concept that innate immune responses to distinctive bacterial cues directly lead to insulin resistance. Expand
...
1
2
...